IPP Bureau
Glenmark and Cediprof inks exclusive distribution agreement in US
By IPP Bureau - March 10, 2023
The agreement is for USFDA approved Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets
Zydus receives final approval from the USFDA for Erythromycin Tablets
By IPP Bureau - March 10, 2023
Erythromycin Tablets USP, 250 mg and 500 mg are used to prevent and treat infections in many different parts of the body
Alembic receives USFDA tentative approval for Brexpiprazole Tablets
By IPP Bureau - March 10, 2023
Clariant launches Plantasens Pro LM
By IPP Bureau - March 10, 2023
Plantasens Pro LM is 100% natural, readily biodegradable, COSMOS and Natrue certified
Atlas Copco acquires FS Medical’s medical gas systems
By IPP Bureau - March 10, 2023
The business serves the healthcare and laboratory sectors on the west coast of the United States.
SRL Diagnostics partners with PathPresenter to enable digital pathology consultations
By IPP Bureau - March 10, 2023
This new capability represents a significant shift from a microscope-based standard of care to the use of digital whole slide images
Siegfried opens global development center for drugs in Spain
By IPP Bureau - March 10, 2023
The Development Center with its state-of-the art laboratories and flexible pilot capacities is set to become Siegfried's global research and development hub for its Drug Products sites, strengthening the global network
Ashland Hyderabad laboratory receives ISO certification
By IPP Bureau - March 09, 2023
Ashland’s pharmaceutical business is well known for acetylenics, cellulosics, and film coatings
Evonik and BellaSeno advance commercialization of 3D-printed, bioresorbable implants
By IPP Bureau - March 09, 2023
Resomer used in commercial 3D-printed implants for both soft and hard tissue applications
Evonik opens new facility for pharmaceutical lipids in Germany
By IPP Bureau - March 09, 2023
New GMP facility for clinical and small-scale commercial pharmaceutical lipids
Alembic receives USFDA final approval for Prazosin Hydrochloride Capsules
By IPP Bureau - March 09, 2023
Prazosin Hydrochloride Capsule is indicated for the treatment of hypertension, to lower blood pressure
Eugia Pharma receives USFDA approval for Lenalidomide Capsules
By IPP Bureau - March 09, 2023
The approved product is indicated for the treatment of adult patients with Multiple myeloma, in combination with Dexamethasone
Caplin Steriles gets USFDA approval for Thiamine Hydrochloride Injection
By IPP Bureau - March 09, 2023
Thiamine Hydrochloride Injection is effective in the treatment of vitamin B1 deficiency (beriberi)
Jubilant Pharmova receives VAI from USFDA for its API manufacturing facility
By IPP Bureau - March 09, 2023
Based on this inspection and the USFDA VAI classification, this facility is in compliance with regard to current good manufacturing practices (cGMP)
Lonza upgrades powder characterization capabilities at Tampa
By IPP Bureau - March 09, 2023
The new powder flow tester can characterize powder flow properties, offering valuable insight for pharmaceutical processing and formulation
